GLN-URSODIOL

glenmark pharmaceuticals canada inc.🇨🇦 Health Canada

Approval Id: d66d15acb726940e
Drug Approval Canada Name: GLN-URSODIOL
Product Name: GLN-URSODIOL
Status: Marketed
Status Date: 2021-07-23
Original Market Date: 2016-04-04
Din: 02426919
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 56:14.00
Atc Original: A05AA02 URSODEOXYCHOLIC ACID
Atc Name: a 05 aa 02
Aig Number: 0122789002
Company Name: glenmark pharmaceuticals canada inc.
Company Address: 1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2

URSODIOL

500 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d66d15acb726940e

Type

Standard